drugset / Trial / NCT05787002

A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin.

NCT05787002

Phase 1 Completed 16 enrolled AstraZeneca
RandomizedCrossoverOpen-labelOther

Summary

The purpose of the study is to assess the effect of AZD0780 on the pharmacokinetics of rosuvastatin, and to assess the safety and tolerability of AZD0780 single dose, in healthy participants administered alone and in combination with rosuvastatin.

Timeline

Start
2023-03-09
Primary completion
2023-05-15
Completion
2023-05-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Laroprovstat Small molecule Oral
Subject Rosuvastatin Small molecule Oral

Indications